Connection

Daniele Focosi to Antibodies, Monoclonal

Back to Details
This is a "connection" page, showing publications Daniele Focosi has written about Antibodies, Monoclonal.
Daniele Focosi
Connection Strength
0.718
Antibodies, Monoclonal
  1. SARS-CoV-2 Variants: A Synopsis of In Vitro Efficacy Data of Convalescent Plasma, Currently Marketed Vaccines, and Monoclonal Antibodies. Viruses. 2021 06 23; 13(7).
    View in: PubMed
    Score: 0.230
  2. Neutralising antibody escape of SARS-CoV-2 spike protein: Risk assessment for antibody-based Covid-19 therapeutics and vaccines. Rev Med Virol. 2021 11; 31(6):e2231.
    View in: PubMed
    Score: 0.226
  3. Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline. MAbs. 2020 Jan-Dec; 12(1):1854149.
    View in: PubMed
    Score: 0.208
  4. Viral infection neutralization tests: A focus on severe acute respiratory syndrome-coronavirus-2 with implications for convalescent plasma therapy. Rev Med Virol. 2021 03; 31(2):e2170.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.